Penalty Amount
$103,420
The FTC distributed refunds to consumers who purchased deceptively marketed treatment plans from Golden Sunrise Nutraceutical. The company and its medical director were barred from making unsupported health claims about curing COVID-19, cancer, and Parkinson's disease after a court order in September 2025. Over $40,700 was sent to 578 consumers, with additional claims possible until May 2026.
Defendants were ordered to pay $103,420 in monetary penalties, barred from making unsupported health claims in the future, and required to provide refunds to affected consumers totaling over $40,700.
In-house legal teams should review all customer-facing agreements (including sales contracts, terms of service, and marketing partnership agreements) and vendor agreements where marketing materials or product descriptions are provided. Focus on representations and warranties clauses regarding the accuracy of marketing claims, compliance with FTC Act Section 5, and product efficacy statements. Specific clauses to scrutinize include those governing marketing material approval processes, indemnification for regulatory actions, and termination rights for breach of compliance obligations. Changes may be needed to require pre-approval of any health-related claims, mandate documented scientific evidence for efficacy statements, and include explicit prohibitions against claiming products can cure specific diseases like COVID-19, cancer, or Parkinson's without FDA review and approval.
Entity
Golden Sunrise Nutraceutical, Inc.
Also known as: Golden Sunrise Nutraceutical
Industry
HealthcareOfficial Press Release
https://www.ftc.gov/news-events/news/press-releases/2026/02/ftc-sends-checks-consumers-who-bought-certain-products-golden-sunrise-nutraceutical-between-2017
promoter 23000 covid 19 treatment plan barred making bogus h
https://www.ftc.gov/news-events/news/press-releases/2021/06/promoter-23000-covid-19-treatment-plan-barred-making-bogus-health-claims
GoldenSunrise Order
https://www.ftc.gov/system/files/ftc_gov/pdf/GoldenSunrise-Order.pdf
ftc announces refund claims process consumers who bought dec
https://www.ftc.gov/news-events/news/press-releases/2025/01/ftc-announces-refund-claims-process-consumers-who-bought-deceptively-marketed-golden-sunrise
GoldenSunrise
https://www.ftc.gov/GoldenSunrise
Federal Trade Commission Enforcement Page
https://www.ftc.gov/enforcement
"Golden Sunrise Nutraceutical, Inc."
"ordered to pay $103,420"
"deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19, and used false or unproven claims that other treatment plans could cure cancer and Parkinson’s disease"
"578 affected consumers"
"In September 2025"
"barred them from making unsupported health claims in the future"
$750K
The FTC finalized an order against Vanilla Chip LLC (doing business as TruHeight) and its principals for deceptively advertising height-enhancing supplements for children and teens without scientific evidence. The company also used fake reviews and incentivized 5-star ratings. The order requires a $750,000 payment and prohibits false health claims and deceptive review practices.
$2.3M
The FTC alleged that RentGrow, a tenant screening company, violated the Fair Credit Reporting Act (FCRA) by failing to use reasonable procedures to ensure the accuracy of its reports, including by reporting duplicate records and failing to disclose data sources. RentGrow agreed to pay a $2.25 million penalty and is prohibited from further FCRA violations and from misrepresenting dispute outcomes.
The FTC and New York Attorney General took action against Handy Technologies for deceptive earnings claims and failure to disclose fees and fines that led to millions of dollars being withheld from workers' wages. The FTC is sending over $2.7 million in refunds to 62,893 affected consumers.
$35.0M
The FTC alleged that Hopper, a travel booking app, charged consumers hidden and pre-selected fees (Tip and VIP Support) without their consent, misrepresented the benefits of VIP Support and Price Freeze services, and failed to clearly disclose total prices. Hopper agreed to pay $35 million for consumer redress and is prohibited from misrepresenting fees under a proposed order.
$1.5M
The FTC finalized a settlement with Publishing.com LLC and its principals for misleading consumers about potential earnings from self-publishing products. The company will pay $1.5 million and is prohibited from making unsubstantiated earnings claims, failing to disclose refund terms, and misrepresenting endorsements and reviews.
The FTC is seeking public comment on a proposed policy statement addressing concerns that AI companies may be manipulating AI system outputs contrary to consumer expectations for objectivity and accuracy. The statement explains that such conduct could be considered deceptive under Section 5 of the FTC Act. The public comment period runs until July 31, 2026.